Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellular and Biocellular Therapy in Musculoskeletal Disorders
NCT03090672Unknown
- Start
- Mar 2017
- Primary completion
- Aug 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of autologous adipose stromal vascular fraction in Musculoskeletal pain, osteoarthritis (OA), tendinopathy and 3 more (3 arms). Primary endpoint: Participants with complications at 1 month. Status: unknown.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
Musculoskeletal painosteoarthritis (OA)tendinopathytendinosisback pain
Beyond the preview
Go deeper on NCT03090672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090672.